Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$5.72 - $8.8 $76,081 - $117,048
13,301 New
13,301 $106,000
Q4 2022

Feb 10, 2023

BUY
$6.09 - $7.93 $106,471 - $138,640
17,483 New
17,483 $109,000
Q3 2020

Nov 13, 2020

SELL
$14.88 - $20.13 $229,315 - $310,223
-15,411 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$13.31 - $20.51 $205,120 - $316,079
15,411 New
15,411 $281,000
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $444,066 - $749,670
-23,508 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $490,847 - $603,215
23,508 New
23,508 $513,000
Q2 2019

Aug 14, 2019

SELL
$20.52 - $26.45 $808,693 - $1.04 Million
-39,410 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$20.23 - $26.29 $288,823 - $375,342
14,277 Added 56.81%
39,410 $973,000
Q4 2018

Feb 15, 2019

BUY
$17.64 - $28.32 $75,640 - $121,436
4,288 Added 20.57%
25,133 $464,000
Q3 2018

Nov 15, 2018

BUY
$20.64 - $25.67 $430,240 - $535,091
20,845 New
20,845 $535,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.